» Articles » PMID: 15209516

Properties of Human Vasopressin Precursor Constructs: Inefficient Monomer Folding in the Absence of Copeptin As a Potential Contributor to Diabetes Insipidus

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2004 Jun 24
PMID 15209516
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

These studies were aimed at an initial characterization of the human vasopressin precursor and the evaluation of factors leading to misfolding by the pathological 87STOP mutation. This mutation deletes the precursor's glycosylated copeptin segment, which has been considered unnecessary for folding, and the last seven neurophysin residues. We investigated the role in folding of the last seven neurophysin residues by comparing the properties of the 87STOP precursor and its derivative neurophysin with those of the corresponding wild-type proteins from which copeptin had been deleted, leading to the following conclusions. First, despite modulating effects on several protein properties, the last seven neurophysin residues do not make a significant net thermodynamic contribution to precursor folding; stabilities of the mutant and wild-type precursors to both guanidine denaturation and redox buffer unfolding are similar, as are in vitro folding rates. Second, the monomeric forms of both precursors are unstable and predicted to fold inefficiently at physiological pH and temperature, as evidenced by precursor behavior in redox buffers and by thermodynamic calculations. Third, both precursors are significantly less stable than the bovine oxytocin precursor. These results, together with earlier studies elsewhere of vasopressin precursor behavior within rat neurons, are shown to represent a self-consistent argument for a role for glycosylated copeptin in vasopressin precursor folding in vivo, copeptin most probably assisting refolding by facilitating interaction of misfolded monomers with the calnexin/calreticulin system. This hypothesis provides an explanation for the absence of copeptin in the more stable oxytocin precursor and suggests that the loss of copeptin contributes to 87STOP pathogenicity. Reported cell culture studies of rat precursor folding are also discussed in this context. Most generally, the results emphasize the significance of monomer stability in the folding pathways of oligomeric proteins.

Citing Articles

Prognostic role of serum copeptin levels in adults with graded traumatic brain injury.

Demir O, Az A, Cakmak S, Sogut O Ir J Med Sci. 2024; 194(1):353-360.

PMID: 39392564 DOI: 10.1007/s11845-024-03818-y.


Association of Preoperative Copeptin Levels with Risk of All-Cause Mortality in a Prospective Cohort of Adult Cardiac Surgery Patients.

Filipovic M, Huber M, Kobel B, Bello C, Levis A, Andereggen L Cells. 2024; 13(14.

PMID: 39056779 PMC: 11274732. DOI: 10.3390/cells13141197.


Preoperative Serum Copeptin Can Predict Delayed Hyponatremia after Pituitary Surgery in the Absence of Arginine Vasopressin Deficiency.

Kang H, Park S, Kim Y, Lim H, Lee M, Lee K Endocrinol Metab (Seoul). 2024; 39(1):164-175.

PMID: 38171208 PMC: 10901654. DOI: 10.3803/EnM.2023.1792.


New insights on diagnosis and treatment of AVP deficiency.

Refardt J, Atila C, Christ-Crain M Rev Endocr Metab Disord. 2023; 25(3):639-649.

PMID: 38087160 PMC: 11162367. DOI: 10.1007/s11154-023-09862-w.


Review novel insights into the diagnostic and prognostic function of copeptin in daily clinical practice.

Wu P, Wang L, Su X, Wang B, Cheng Y Mol Biol Rep. 2023; 50(4):3755-3765.

PMID: 36662451 PMC: 9853489. DOI: 10.1007/s11033-023-08246-2.